Literature DB >> 1461373

[3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine.

H C Akunne1, B R de Costa, A E Jacobson, K C Rice, R B Rothman.   

Abstract

We studied the characteristics of [3H]cocaine binding to membranes prepared from whole guinea pig brain. Cocaine binding was specific and saturable. A one-site binding model fit the data adequately: the Kd value of [3H]cocaine was 44 nM with a Bmax value of 280 fmol/mg protein. The rank order of potency for the [3H]cocaine binding site was paroxetine > clomipramine > (-)-cocaine > fluoxetine > mazindol > desipramine > GBR12909 > phencyclidine > benztropine > GBR12935 > (+)-cocaine. The IC50 values of these drugs for inhibition of [3H]cocaine binding were highly correlated with their IC50 values for inhibition of [3H]5-HT uptake into synaptosomes prepared from whole guinea pig brain. High affinity 5-HT uptake inhibitors produced dose-dependent wash-resistant (pseudoirreversible) inhibition of [3H]cocaine binding. The wash-resistant inhibition produced by paroxetine was due to an increase in the Kd of [3H]cocaine binding sites, and was accompanied by an increase in the dissociation rate, consistent with an allosteric mechanism. These studies suggest that, using membranes prepared from whole guinea pig brain, [3H]cocaine labels a binding site associated with serotonin transporter and that paroxetine and cocaine bind to different sites on the serotonin transporter.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461373     DOI: 10.1007/bf00968412

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.

Authors:  C R Ashby; L H Jiang; R Y Wang
Journal:  Eur J Pharmacol       Date:  1990-01-17       Impact factor: 4.432

2.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

3.  Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam.

Authors:  A Imperato; S Puglisi-Allegra; A Zocchi; M G Scrocco; P Casolini; L Angelucci
Journal:  Eur J Pharmacol       Date:  1990-01-10       Impact factor: 4.432

4.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

Authors:  L H Jiang; C R Ashby; R J Kasser; R Y Wang
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

5.  The pharmacological relevance of the cocaine binding site in mouse brain.

Authors:  H Sershen; M E Reith; A Lajtha
Journal:  Neuropharmacology       Date:  1980-11       Impact factor: 5.250

6.  beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.

Authors:  R B Rothman; J B Long; V Bykov; A E Jacobson; K C Rice; J W Holaday
Journal:  J Pharmacol Exp Ther       Date:  1988-11       Impact factor: 4.030

7.  The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.

Authors:  R B Rothman; A A Reid; J A Monn; A E Jacobson; K C Rice
Journal:  Mol Pharmacol       Date:  1989-12       Impact factor: 4.436

8.  Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites.

Authors:  L T Kennedy; I Hanbauer
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

9.  A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.

Authors:  M E Reith; H Sershen; D L Allen; A Lajtha
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

10.  Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.

Authors:  E B De Souza; B L Kuyatt
Journal:  Synapse       Date:  1987       Impact factor: 2.562

View more
  9 in total

1.  Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release.

Authors:  Joseph J Pariser; John S Partilla; Christina M Dersch; Subramaniam Ananthan; Richard B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2008-04-25       Impact factor: 4.030

2.  The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents.

Authors:  Adam L Halberstadt; Natalia Slepak; James Hyun; Mahalah R Buell; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2016-01-13       Impact factor: 4.530

3.  A fluorescence displacement assay for antidepressant drug discovery based on ligand-conjugated quantum dots.

Authors:  Jerry C Chang; Ian D Tomlinson; Michael R Warnement; Hideki Iwamoto; Louis J DeFelice; Randy D Blakely; Sandra J Rosenthal
Journal:  J Am Chem Soc       Date:  2011-10-17       Impact factor: 15.419

4.  Studies of the biogenic amine transporters. 1. Dopamine reuptake blockers inhibit [3H]mazindol binding to the dopamine transporter by a competitive mechanism: preliminary evidence for different binding domains.

Authors:  C M Dersch; H C Akunne; J S Partilla; G U Char; B R de Costa; K C Rice; F I Carroll; R B Rothman
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

5.  The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.

Authors:  Meng-Yang Zhu; Patrick B Kyle; Arthur S Hume; Gregory A Ordway
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

6.  Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.

Authors:  Q Ni; H Xu; J S Partilla; B R de Costa; K C Rice; A Borsodi; S Hosztafi; R B Rothman
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

Review 7.  A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.

Authors:  R B Rothman; J R Glowa
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

8.  Studies of the biogenic amine transporters. 13. Identification of "agonist" and "antagonist" allosteric modulators of amphetamine-induced dopamine release.

Authors:  Richard B Rothman; Christina M Dersch; Subramaniam Ananthan; John S Partilla
Journal:  J Pharmacol Exp Ther       Date:  2009-02-24       Impact factor: 4.030

9.  Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.

Authors:  Bruce A Davis; Anu Nagarajan; Lucy R Forrest; Satinder K Singh
Journal:  Sci Rep       Date:  2016-04-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.